Abstract
In this issue of Blood, Dhodapkar et al1 present the first US cooperative group trial in asymptomatic monoclonal gammopathies that prospectively examines state-of-the-art laboratory, genomic, and imaging as potential predictors for progression to active multiple myeloma.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 4-5 |
| Number of pages | 2 |
| Journal | Blood |
| Volume | 123 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 2 2014 |
ASJC Scopus subject areas
- Biochemistry
- Immunology
- Hematology
- Cell Biology